T. thermophilus enoyl-acyl carrier protein reductase was crystallized in the apo form, with NAD+ bound and with NAD+ and the inhibitor triclosan bound. The structures were solved by molecular replacement and refined at 1.50, 1.86 and 1.90 Å resolution, respectively. The structures are described, analysed and compared with those of enoyl-acyl carrier protein reductases from other species.
Keywords: enoyl-acyl carrier protein reductases, Thermus thermophilus, triclosan, fatty-acid synthesis
Abstract
Enoyl-acyl carrier protein reductase (ENR; the product of the fabI gene) is an important enzyme that is involved in the type II fatty-acid-synthesis pathway of bacteria, plants, apicomplexan protozoa and mitochondria. Harmful pathogens such as Mycobacterium tuberculosis and Plasmodium falciparum use the type II fatty-acid-synthesis system, but not mammals or fungi, which contain a type I fatty-acid-synthesis pathway consisting of one or two multifunctional enzymes. For this reason, specific inhibitors of ENR are attractive antibiotic candidates. Triclosan, a broad-range antibacterial agent, binds to ENR, inhibiting fatty-acid synthesis. As humans do not have an ENR enzyme, they are not affected. Here, high-resolution structures of Thermus thermophilus (Tth) ENR in the apo form, bound to NAD+ and bound to NAD+ plus triclosan are reported. Differences from and similarities to other known ENR structures are reported; in general, the structures are very similar. The cofactor-binding site is also very similar to those of other ENRs and, as reported for other species, triclosan leads to greater ordering of the loop that covers the cofactor-binding site, which, together with the presence of triclosan itself, presumably provides tight binding of the dinucleotide, preventing cycling of the cofactor. Differences between the structures of Tth ENR and other ENRs are the presence of an additional β-sheet at the N-terminus and a larger number of salt bridges and side-chain hydrogen bonds. These features may be related to the high thermal stability of Tth ENR.
1. Introduction
Enoyl-acyl carrier protein reductase (ENR) is an important enzyme that is involved in the type II fatty-acid-synthesis (FAS) pathway in bacteria, plants, apicomplexan protozoa and mitochondria (Massengo-Tiassé & Cronan, 2009 ▶). Harmful pathogens such as Mycobacterium tuberculosis and Plasmodium falciparum use the FAS II system, but not mammals or fungi, which have an FAS I system that consists of one or two multifunctional enzymes, respectively (Leibundgut et al., 2008 ▶). For this reason, specific inhibitors of ENR are attractive antibiotic candidates. ENR is encoded by the fabI gene (Bergler et al., 1994 ▶) and catalyses the last step of the elongation cycle in the synthesis of fatty acids. Structures of ENR from the bacteria M. tuberculosis (Dessen et al., 1995 ▶), Escherichia coli (Baldock et al., 1996 ▶), M. leprae (Wang et al., 2007 ▶), Helicobacter pylori (Lee et al., 2007 ▶), Bacillus anthracis (Tipparaju et al., 2008 ▶), Francisella tularensis (Lu et al., 2009 ▶), Staphylococcus aureus (Priyadarshi et al., 2010 ▶), B. cereus (Kim et al., 2010 ▶) and B. subtilis (Kim et al., 2011 ▶), oil seed rape (Brassica napus; Roujeinikova, Sedelnikova et al., 1999 ▶), the malaria parasite P. falciparum (Perozzo et al., 2002 ▶), the mammalian parasite Toxoplasma gondii (Muench et al., 2007 ▶) and the chicken parasite Eimeria tenella (Lu et al., 2007 ▶) have been described either alone or in complex with cofactors and/or inhibitors. Structures of ENR from other species such as the parasite P. berghei (PDB entry 3f4b; M. Yu et al., unpublished work) and the bacteria Aquifex aeolicus (PDB entry 2p91; Southeast Collaboratory for Structural Genomics and RIKEN Structural Genomics/Proteomics Initiative, unpublished work), Burkholderia pseudomallei (PDB entry 3ek2; Seattle Structural Genomics Center for Infectious Disease, unpublished work) and Anaplasma phagocytophilum (PDB entries 3k2e and 3k31; Seattle Structural Genomics Center for Infectious Disease, unpublished work) have also been submitted to the Protein Data Bank.
Triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether) is a broad-range antibacterial agent that is used in soaps, mouthwashes, toothpaste and other products; bathing in 2%(w/v) triclosan is an accepted regime for decolonizing methicillin-resistant Staphylococcus aureus patients. Triclosan binds to ENR, increasing its affinity for NAD+ and resulting in the formation of a stable ternary ENR–NAD+–triclosan complex which is unable to participate in fatty-acid synthesis (Levy et al., 1999 ▶; Roujeinikova, Levy et al., 1999 ▶). As humans do not have an ENR enzyme, they are not affected.
Here, we present the structure of ENR from Thermus thermophilus, which is an extremely thermophilic, Gram-negative, aerobic, rod-shaped bacterium. T. thermophilus was isolated from a natural geothermal environment in Japan and can grow at temperatures of up to 385 K, with an optimal growth temperature of 343 K (Oshima, 1974 ▶). Although structures of Tth ENR in the apo form (PDB entry 1ulu; 2.00 Å resolution; RIKEN Structural Genomics/Proteomics Initiative, unpublished work) and bound to NADP+ (PDB entry 2yw9; 2.50 Å resolution; RIKEN Structural Genomics/Proteomics Initiative, unpublished work) are available from the PDB, they have not been described. Here, we report the high-resolution structures of Tth ENR in the apo form, bound to NAD+ and bound to NAD+ plus triclosan. These structures were solved by molecular replacement and refined at 1.50, 1.86 and 1.90 Å resolution, respectively.
2. Materials and methods
2.1. Expression, purification and crystallization
The Tth ENR gene sequence was amplified from T. thermophilus HB8 genomic DNA using the polymerase chain reaction. The resulting DNA fragment encoding Tth ENR (UniProt accession code Q5SLI9) was cleaved with NdeI and SalI and ligated into the expression vector pET30a (Novagen/Merck, Nottingham, England) between the NdeI and XhoI restriction sites (SalI and XhoI produce compatible 5′-TCGA overhangs). The resulting plasmid pET30-Tth ENR encoded all 261 residues of Tth ENR. The sequence of the insert was confirmed by DNA-sequence analysis (Eurofins MWG Operon, Ebersberg, Germany). E. coli strain Rosetta (DE3), obtained from Novagen, was freshly transformed with pET30-Tth ENR and a 0.5 l culture in LB (10 g Bacto tryptone, 5 g Bacto yeast extract and 10 g sodium chloride per litre) supplemented with 20 mg l−1 chloroamphenicol and 25 mg l−1 kanamycin was grown aerobically at 310 K to an optical density of 0.9–1.1 at 600 nm. The culture was cooled on ice and expression was induced with 1 mM isopropyl β-d-1-thiogalactopyranoside, after which growth was allowed to continue overnight (12–16 h at 293 K). The cells were harvested by centrifugation at 3500g for 20 min at 277 K and the resulting pellet was resuspended in 10 ml buffer A [20 mM Tris–HCl pH 7.5, 1 mM ethylenediamine tetraacetate (EDTA)] and frozen at 253 K. The frozen pellet was thawed on ice, phenylmethanesulfonyl fluoride was added to a final concentration of 1 mM and the bacteria were lysed by a triple pass through an emulsifier (Avestin Emulsifier C5, Avestin Europe GmbH, Mannheim, Germany). From this point onwards, all procedures were carried out at 277 K unless stated otherwise. The lysate was centrifuged at 18 000g for 30 min and the insoluble fraction was removed. The clear supernatant was incubated for 15 min at 343 K in a water bath with constant shaking and was then immediately cooled on ice for 15 min. The resulting suspension was centrifuged at 18 000g for 15 min and the insoluble fraction was removed. Ammonium sulfate was added slowly to the supernatant fraction to 55% saturation and the resulting suspension was centrifuged at 18 000g for 30 min. Ammonium sulfate was then added to the supernatant to 75% saturation and after centrifugation as before the pellet was resuspended in a minimal amount of buffer A and dialysed three times against 1 l of the same buffer. The sample was then loaded onto a strong anion-exchange column (Uno-Q6, 6 ml bed volume; Bio-Rad, Madrid, Spain), which had previously been equilibrated with buffer A, at a flow rate of 1.0 ml min−1. The protein was eluted with a linear gradient of 0.0–1.0 M sodium chloride in buffer A. Tth ENR eluted right at the start of the gradient and the purified fractions containing Tth ENR were pooled and dialysed twice against 1 l buffer B [20 mM 2-(N-morpholino)ethanesulfonic acid–NaOH pH 6.0, 1 mM EDTA, 10%(v/v) glycerol]. The sample was loaded onto a strong cation-exchange column (BioRad Uno-S6, 6 ml bed volume), which had previously been equilibrated with buffer B, at a flow rate of 1.0 ml min−1. The protein was eluted with a linear gradient of 0.0–1.0 M sodium chloride in buffer B. The protein eluted at around 100 mM sodium chloride and the pooled fractions were concentrated in Amicon Ultra-15 concentrators (Millipore, Madrid, Spain), incorporating three washes with buffer A to remove low-molecular-weight impurities. The purity of the protein was established by Coomassie Brilliant Blue stained 15% SDS–PAGE according to the method of Laemmli (1970 ▶). The protein concentration was determined by spectrophotometric measurements at 280 nm using an estimated extinction coefficient of ∊ = 0.75 l g−1 cm−1 (NanoDrop ND-1000, Wilmington, Delaware, USA).
2.2. Crystallization, structure solution and refinement
For crystallization, drops consisting of 2 µl Tth ENR at approximately 4 mg ml−1 mixed with 2 µl reservoir solution were equilibrated against 0.15 ml reservoir solution at 291 K. Plate-shaped crystals of apo Tth ENR were obtained by sitting-drop vapour diffusion using 20%(w/v) polyethylene glycol 4000 in 100 mM sodium citrate pH 5.4 as the precipitant solution. NAD+ was dissolved to 2 mM in Tth ENR solution at 4 mg ml−1 and Tth ENR–NAD+ crystals were obtained using 32%(w/v) polyethylene glycol 4000 in the same buffer as the precipitant solution. To obtain Tth ENR–NAD+–triclosan crystals, Tth ENR–NAD+ crystals were soaked for 48 h in crystallization solution (Tth ENR–NAD+ solution plus precipitant solution) containing 3.2 mM triclosan (Sigma–Aldrich Quimica SA, Madrid, Spain). Crystals were flash-cooled in liquid nitrogen using crystallization solution with 10%(w/v) glycerol as a cryoprotectant. Crystallographic data were collected at 100 K on beamline ID14-4 at ESRF, Grenoble, France for the apo Tth ENR and Tth ENR–NAD+ complex crystals and on beamline X11 at DESY, Hamburg, Germany for the Tth ENR–NAD+–triclosan complex crystals.
Crystallographic data were processed using MOSFLM (Powell, 1999 ▶; Leslie, 2006 ▶), scaled using SCALA (Evans, 2006 ▶) and further treated using other programs from the CCP4 program suite (Winn et al., 2011 ▶). The structure of the apo form was solved by molecular replacement using the program Phaser (McCoy et al., 2007 ▶) with a monomer of PDB entry 1ulu as a search model. For the NAD+ and NAD+/triclosan complex structures MOLREP (Vagin & Teplyakov, 2010 ▶) and monomer A of the apo form (PDB entry 2wyu) were used. Atomic coordinates, molecular topologies and geometric restraints for NAD+ and triclosan were generated with the PRODRG2 server (Schüttelkopf & van Aalten, 2004 ▶). The resulting models were rebuilt with Coot (Emsley & Cowtan, 2004 ▶) and refined with REFMAC (Murshudov et al., 2011 ▶), and ligand fitting was performed manually in the electron-density maps. A few water molecules were replaced by Na atoms as suggested by the WASP application (Nayal & Di Cera, 1996 ▶). Validation was performed with MolProbity (Chen et al., 2010 ▶) and figures were created with PyMOL (Schrödinger LLC, New York, USA). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 2wyu for apo Tth ENR, 2wyv for Tth ENR bound to NAD+ and 2wyw for Tth ENR bound to NAD+ and triclosan.
3. Results and discussion
Full-length nontagged T. thermophilus enoyl-acyl carrier protein reductase (Tth ENR) was expressed in E. coli and purified. For purification, advantage was taken of the thermal resistance of the protein by incorporating a heat-treatment step to denature and precipitate endogenous E. coli proteins. After centrifugation, supernatants were further purified by ammonium sulfate precipitation and anion-exchange and cation-exchange chromatography as described in §2. The purified protein was crystallized at pH 5.4 using polyethylene glycol 4000 as precipitant. The crystals belonged to space group P21 with one tetramer in the asymmetric unit. To obtain the complex structures, the protein was cocrystallized with NAD+ as described in §2 and triclosan was soaked into pre-existing crystals that already contained NAD+. Data were collected to better than 2.0 Å resolution for all three crystal forms using synchrotron radiation. All of the structures were solved by molecular replacement and refined to good geometry and good agreement with the experimental data (Table 1 ▶).
Table 1. Crystallographic data and refinement statistics.
Values in parentheses are for the highest resolution bin (where applicable).
Apo form | NAD+ complex | NAD+/triclosan complex | |
---|---|---|---|
Data statistics | |||
Wavelength () | 0.939 | 0.939 | 0.815 |
Detector | ADSC Q315r CCD | ADSC Q315r CCD | MAR 555 flat panel |
Crystal-to-detector distance (mm) | 230.6 | 295.7 | 300.0 |
Space group | P21 | P21 | P21 |
Unit-cell parameters (, ) | a = 54.3, b = 107.8, c = 86.0, = = 90.0, = 95.9 | a = 53.5, b = 107.4, c = 84.8, = = 90.0, = 94.9 | a = 57.7, b = 127.5, c = 66.5, = = 90.0, = 108.2 |
Unique observations | 151147 (19108) | 77770 (10441) | 65244 (8528) |
Resolution range () | 15.01.50 (1.581.50) | 40.01.86 (1.961.86) | 30.01.90 (2.001.90) |
Multiplicity | 2.9 (2.3) | 2.9 (2.5) | 3.5 (3.5) |
Completeness (%) | 96.4 (83.8) | 95.9 (89.2) | 91.2 (82.1) |
Mean I/(I) | 8.7 (2.0) | 10.1 (2.2) | 10.5 (2.9) |
R merge † | 0.062 (0.299) | 0.064 (0.407) | 0.071 (0.393) |
Wilson B (2) | 18.9 | 21.5 | 21.5 |
Refinement | |||
Resolution range () | 15.01.50 | 40.01.86 | 30.01.90 |
No. of reflections used | 149093 | 76657 | 62991 |
No. of reflections for R free | 2001 | 1098 | 2198 |
R factor | 0.170 | 0.182 | 0.155 |
R free | 0.200 | 0.239 | 0.196 |
No. of protein atoms | 7754 | 7716 | 7876 |
No. of ligand atoms | 0 | 88 | 244 |
No. of solvent atoms | 1079 | 548 | 675 |
Average B factors (2) | |||
Protein | 21.8 | 27.7 | 22.5 |
Ligand | 49.3 | 18.3 | |
Solvent | 35.4 | 36.2 | 32.6 |
R.m.s.d. values | |||
Bonds () | 0.015 | 0.016 | 0.014 |
Angles () | 1.5 | 1.5 | 1.5 |
Ramachandran statistics | |||
Favoured | 984 | 978 | 997 |
Allowed | 16 | 23 | 28 |
Outliers | 0 | 1 | 0 |
R
merge =
, where I
i(hkl) is the intensity of the ith measurement of the same reflection and I(hkl) is the mean observed intensity for that reflection.
Some residues belonging to the C-termini of all of the structures could not be modelled owing to a lack of electron density; presumably these are flexible parts of the protein. Also disordered were residues Thr195–Gly203 of chain B and Arg194–Met207 of chain D on the surface of the apo Tth ENR structure and Ser200–Thr205 of chain D and Val196–Met207 of chain B on the surface of the Tth ENR–NAD+ structure. It is likely that these are flexible and inspection of the crystal packing shows that in monomers A and C of those two structures the equivalent residues are held in place by crystal contacts. One Ramachandran outlier, Arg194 in chain D, is present in the Tth ENR–NAD+ structure; this residue is located next to one of the disordered surface stretches. In the Tth ENR–NAD+–triclosan structure the same regions are ordered in all four monomers, presumably owing to triclosan binding to the active site, which provides a link between the NAD+ and the loop that covers the active site. The Tth ENR–NAD+–triclosan structure contained 40% solvent, while the other two structures contained 45% solvent. Remarkably, the triclosan-soaking process appears to have caused significant changes in the unit-cell parameters (see Table 1 ▶). The tighter packing of the protein in the crystal lattice is related to the ordering of the protein active-site lid presumably caused by the binding of triclosan. A degree of drying out of the crystallization drop owing to the extra manipulations involved in soaking may also have had some influence.
3.1. Overall protein structure
In the three structures that we have determined, Tth ENR forms homotetramers with internal 222 symmetry (Figs. 1 ▶ a, 3a and 4a). This is the same as has been observed for ENRs from other species such as M. tuberculosis (Dessen et al., 1995 ▶). The four monomers lie in a ring, adopting alternate ‘up’ and ‘down’ orientations. Each monomer interacts with its neighbours with two energetically favourable interfaces. One interface (between chains A and B and between chains C and D) comprises 1.8 × 103 Å2 and has a calculated energy gain of −84 kJ mol−1, while the other (between chains A and D and between chains B and C) comprises 1.7 × 103 Å2 and has a calculated energy gain of −117 kJ mol−1 (Krissinel & Henrick, 2007 ▶). Each Tth ENR monomer contains a central seven-stranded parallel β-sheet covered on each face by three α-helices (Figs. 1 ▶ b and 1 ▶ c). The N-terminal residues 2–4 form a short additional β-strand (B0) that interacts with a counterpart from a neighbouring monomer (A with D and B with C), potentially stabilizing the tetramer. On top of the NAD+-binding site, two α-helices are present (A4b and A6). The C-termini of each Tth ENR monomer interact with those from opposite monomers (A with C and B with D); this may also be a tetramer-stabilization interaction.
Figure 1.
Structure of the T. thermophilus enoyl-acyl carrier reductase apo form. (a) Structure of a tetramer. Green, cyan, magenta and yellow colours are used for chains A, B, C and D, respectively. (b) Monomer with secondary-structure elements labelled. (c) Topology diagram. α-Helices are coloured red and β-strands yellow.
The topology of the monomer is similar to those of other dehydrogenases (Rossmann et al., 1975 ▶) and is virtually identical to those of M. tuberculosis (Dessen et al., 1995 ▶), H. pylori (Lee et al., 2007 ▶) and E. coli (Rafi et al., 2006 ▶) ENRs (Figs. 2 ▶ a and 2 ▶ b). Principal differences arise from the lid that covers the nicotinamide-binding site (Gly191–Gly203 in Tth ENR), apart from the now resolved N-terminal β-strand B0 (Fig. 2 ▶ c). The four monomers of the apo structure are also very similar to each other (r.m.s.d. of 0.13–0.14 Å for 201–208 Cα-atom pairs), with the only significant differences occurring in the residues flanking the disordered region spanning residues 194–207. When we structurally compare Tth ENR (subunit A of the apo structure) with the apo structure of ENR from H. pylori (PDB entry 2pd3; Lee et al., 2007 ▶), the r.m.s.d. is 0.72 Å for 214 superposed Cα-atom pairs. The r.m.s.d. increases to 0.79 Å for 206 superposed Cα-atom pairs when we compare the Tth ENR monomer with the apo structure of ENR from E. coli (PDB entry 2fhs; Rafi et al., 2006 ▶) and to 1.05 Å for 195 superposed Cα-atom pairs with the apo structure of ENR from M. tuberculosis (PDB entry 1eny; Dessen et al., 1995 ▶).
Figure 2.
(a) Alignment of ENR sequences from T. thermophilus, E. coli, H. pylori and M. tuberculosis. Secondary structure as determined for the T. thermophilus structure is indicated (a, α-helix; b, β-strand). The sequence of the lid of the active site is indicated in bold. (b) Superposition of ENR from T. thermophilus (red; PDB entry 2wyu), E. coli (green; PDB entry 2fhs), H. pylori (yellow; PDB entry 2pd3) and M. tuberculosis (cyan; PDB entry 1eny). The region of the most pronounced structural variation is indicated by an ellipse. (c) Detailed view of the N-terminal interactions between dimers of ENR from T. thermophilus (cyan/magenta) and E. coli (red/orange).
The crystallographic and likely biological units of Tth ENR are homotetramers, which are packed in the crystal lattice forming parallel layers. Similar homotetramers have been observed in the crystallographic packing of ENRs from H. pylori, M. tuberculosis, P. falciparum, F. tularensis, E. tenella, A. phagocytophilum, B. anthracis and P. berghei. The main interactions between monomers involved in the formation of the tetramer are 20 salt bridges between chains A and B and between chains C and D (Asp70 with Arg111, Arg105 with Glu133 and Arg111 with Glu119), between chains B and D and between chains A and C (Glu151 with Lys152) and between chains A and D and between chains B and C (Glu244 with His253), and 12 side-chain hydrogen bonds between chains A and B and between chains C and D (Tyr106 with Ser170), between chains B and D and between chains A and C (Tyr148 with Lys152) and between chains A and D and between chains B and C (Glu225 with Ser239) (Table 2 ▶). There are no important differences in the quaternary structure between the apo, NAD+-bound and NAD+/triclosan-bound Tth ENR forms. The inclusion of NAD+ in the active site of Tth ENR does not cause considerable differences with respect to the apo form in the crystallographic unit-cell parameters and the atomic unit-cell content. However, the inclusion by soaking of triclosan in the active site of Tth ENR–NAD+ causes a tighter packing of the tetramers in the crystallographic lattice. When we compare subunit A of the Tth ENR apo structure with subunit B of the Tth ENR–NAD+ structure and subunit A of the Tth ENR–NAD+–triclosan structure, the r.m.s.d.s are 0.45 and 0.37 Å for 215 and 209 Cα-atom pairs, respectively. When subunit B of the Tth ENR–NAD+ structure and subunit A of the Tth ENR–NAD+–triclosan structure are compared, the r.m.s.d. is 0.31 Å for 242 Cα-atom pairs.
Table 2. Salt bridges and side-chain hydrogen bonds in T. thermophilus, E. coli and M. tuberculosis ENR.
Homologous interactions are shown on the same row. An asterisk indicates an intermolecular interaction between monomers.
Salt bridges | Side-chain hydrogen bonds | ||||
---|---|---|---|---|---|
T. thermophilus ENR | E. coli ENR | M. tuberculosis ENR | T. thermophilus ENR | E. coli ENR | M. tuberculosis ENR |
Asp5/Ser7 | |||||
Lys7/Asp235 | Lys8/Asp248 | ||||
Arg9/Asn86 | |||||
Lys10/Glu36 | Arg9/Gln35 | ||||
Thr17/Ser19 | |||||
His24/Arg27 | |||||
Arg27/Glu31 | |||||
Lys29/Glu32 | |||||
Lys29/Glu224 | |||||
Arg30/Glu31 | |||||
Arg30/Asn227 | |||||
Glu34/Trp82 | |||||
Tyr41/Arg47 | |||||
Tyr41/Glu44 | |||||
Asp42/Arg43 | |||||
Gln42/Asp66 | Gln40/Asp64 | ||||
Arg47/Glu51 | |||||
Gln48/Asp52 | |||||
Arg53/Glu220* | |||||
Arg64/Glu72 | Gln62/Ser70 | ||||
Asp66/Thr68 | |||||
Gln66/Lys118 | |||||
Thr68/Gln69 | |||||
Asp70/Arg111* | Asp68/Arg110* | ||||
Asp70/Arg131 | |||||
Ser73/Arg77 | |||||
Asp74/Arg131 | |||||
Asp88/Arg137 | Asp86/Asn136 | Asp89/Asn139 | |||
His92/Ser124 | His90/Ser123 | His93/Ser126 | |||
His92/Thr144 | His90/Thr143 | ||||
Arg99/Glu103 | |||||
Thr101/Asp115 | |||||
Arg105/Glu133* | Asp103/Arg132* | ||||
Arg105/Asp108 | |||||
Tyr106/Trp114 | |||||
Tyr106/Ser170* | Tyr104/Asn169* | ||||
Asn106/Arg132 | |||||
Arg111/Glu119* | Arg110/Asp118* | ||||
Arg111/Asp70* | Arg110/Asp68* | ||||
His117/Ser165 | |||||
Glu119/Arg111* | Asp118/Arg110* | ||||
Ser121/Ser165 | |||||
Tyr127/Asn172 | |||||
Tyr127/Ser186 | |||||
Arg132/Glu180 | |||||
Glu133/Arg105* | Arg132/Asp103* | ||||
Thr146/Glu168 | Ser145/Glu167 | Asp148/Glu169 | |||
Tyr148/Lys152* | |||||
Asp150/Ser152 | |||||
Ser150/Glu168 | |||||
Glu150/His246 | Glu151/Tyr247 | ||||
Glu151/Lys152* | |||||
Lys152/Glu151* | |||||
Lys152/Tyr148* | |||||
Asn175/Asn257* | |||||
Ser170/Tyr106* | Asn169/Tyr104* | ||||
Asn172/Ser186* | |||||
Arg177/Gln267* | |||||
Glu178/Lys181* | |||||
Arg183/Ser237 | |||||
Lys181/Glu178* | |||||
Ser186/Asn172* | |||||
Asn187/Thr253 | |||||
Arg195/Glu219 | |||||
Arg210/Gln213 | |||||
Arg219/Glu225 | Arg218/Asp224 | ||||
Glu220/Arg53* | |||||
Thr222/Glu224 | Thr221/Glu223 | ||||
Thr222/Glu225 | Thr221/Asp224 | ||||
Glu225/Ser239* | |||||
Ser239/Glu225* | |||||
Glu244/His253* | Glu243/His246* | ||||
His253/Glu244* | His246/Glu243* | ||||
Asn257/Asn175* | |||||
Thr266/Gln267 | |||||
Gln267/Arg177* |
3.2. Cofactor and triclosan binding
In the structure of Tth ENR cocrystallized with NAD+ (Fig. 3 ▶ a), density for the cofactor was only observed in monomers B and D. In monomer B, the density is well defined and the dinucleotide temperature factors refined to an average value of 27 Å2 (Fig. 3 ▶ b). However, the dinucleotide in monomer D had an average temperature factor of 71 Å2 and may therefore be more disordered and/or have partial occupancy. Apart from their NAD+ content, the four crystallographically independent monomers were very similar, with only residues 39–67 showing differences between monomers without NAD+ and with NAD+: they move ‘inwards’ to make more contacts with the adenosine part of NAD+ (Fig. 3 ▶ c). Fig. 3 ▶(d) details the interactions that NAD+ makes with the protein: Gln42, Asp66 and the N atom of Val67 form weak hydrogen bonds to the adenosine moiety (distances of between 2.9 and 3.1 Å). Residues of the loop between strand B1 and helix A1 (Thr17) and of helix A1 itself (Ser21 and Leu22), of the top of helix A5 and of the flexible region (Val193, Thr195 and Ala197) also provide polar contacts and van der Waals interactions with the nicotinamide diphosphate moiety. There are no significant differences in the structure bound to NADP+ (PDB entry 2yw9) and the cofactor is bound in exactly the same way (Fig. 3 ▶ e). The nearby Arg45 would be well placed to interact with the extra phosphate of NADP+, but is disordered in the 2yw9 structure. It is not known whether Tth ENR prefers NADH or NADPH as cofactor.
Figure 3.
(a) Structure of the T. thermophilus ENR tetramer with NAD+ bound in chains B (cyan) and D (yellow). (b) Unbiased electron density for NAD+. A maximum-likelihood weighted 2F o − F c map calculated before including ligands in the model contoured at 2σ (black) is shown up to 1.6 Å around the ligand (green). Chain B of the final model (grey), including the ligand, is superposed onto the map. (c) Comparison of Tth ENR with (light blue) and without (light green) NAD+. Residues 39–67 are highlighted in dark colours. (d) NAD+ contacts. (e) Comparison of NAD+ (blue) and NADP+ (yellow) in the active site. (f) Comparison of ENR from T. thermophilus (green) and M. tuberculosis (cyan) bound to NAD+.
The active site of the ENRs is a large pocket placed in the middle of the protein and covered by a flexible lid (amino acids 191–215 in Tth ENR). There are two cavities, which are capable of being filled by a nicotinamide cofactor and the aliphatic chain of a fatty acid. Triclosan and other diaromatic derivatives can effectively bind in the fatty-acid binding site only when NAD+ is also present, promoting inhibition of the enzyme. The formation of the ENR–NAD+–triclosan complex is highly effective and forces NAD+ to be retained in the active site. This became clear in previously described crystallographic structures of binary (ENR–NAD+) or ternary (ENR–NAD+–triclosan) complexes of ENRs. For instance, the A. phagocytophilum ENR structure contained only one cofactor per dimer in the ENR–NAD+ crystallographic complex (PDB entry 3k31). The E. coli ENR–NAD+ complex (PDB entry 1dfi; Baldock et al., 1996 ▶) contained four cofactors per tetramer, but two of these cofactors showed high average temperature factors compared with the surrounding protein, suggesting that they were bound much more loosely. However, in the structures of all of the ENR–NAD+–triclosan complexes both the cofactor and the inhibitor occupy the active sites of all of the monomers and have similar average temperature factors to the surrounding amino acids. Therefore, as previously suggested by Kuo et al. (2003 ▶), the inhibition of ENRs by triclosan or its derivatives is uncompetitive and triclosan can only effectively bind to the active site in the presence of NAD+. These observations also suggest that ENR tetramers may show an allosteric effect in the reaction mechanism in which the conformation of one monomer may influence the conformations of its neighbours.
When we structurally compare the binary complex Tth ENR–NAD+ (subunit B of the NAD+-bound structure) with the NAD+-bound structure from M. tuberculosis (PDB entry 1eny; Dessen et al., 1995 ▶), the r.m.s.d. is 0.96 Å for 187 paired Cα atoms. NAD+ is bound in a very similar way in both structures despite the active-site lid of M. tuberculosis ENR adopting a more distant position than in Tth ENR, preventing the stabilizing interactions between the lid and the cofactor that we observe (Fig. 3 ▶ f). Another difference is that in M. tuberculosis ENR the loop around residue 200 is extended by nine residues, presumably to allow it to accept precursors of mycolic acids, the long-chained α-branched β-hydroxy fatty acids characteristic of mycobacterial cell walls.
The Tth ENR–NAD+ crystals soaked with triclosan show clear density for NAD+ and triclosan in all four monomers of the structure (Figs. 4 ▶ a and 4 ▶ b). The triclosan molecules make hydrophobic contacts with Met160, Ala197, Ala198 and Ile201 of the protein; the monochloro-substituted aromatic ring of triclosan stacks onto the nicotinamide group of NAD+, while the hydroxyl O atom is at a hydrogen-bonding distance from the hydroxyl O atom of Tyr157 and the C2 hydroxyl of the nicotinamide ribose (Fig. 4 ▶ c). There are no significant differences between the protein structures with and without triclosan. There are also no changes in the NAD+ conformation. The inhibitor occupies a site in the structure next to the cofactor previously occupied by solvent. The loop around residue 200 becomes more ordered, as shown by significantly lower temperature factors, which makes it much harder for the dinucleotide cofactor to leave, thus leading to tighter binding.
Figure 4.
(a) Structure of T. thermophilus ENR with NAD+ and triclosan. The monomers are coloured differently. (b) Unbiased electron density for NAD+ and triclosan. A maximum-likelihood weighted 2F o − F c map calculated before including ligands in the model contoured at 2σ (black) is shown up to 1.6 Å around the ligands (yellow). Chain A of the final model (grey), including the ligands, is superposed onto the map. (c) NAD+ and triclosan contacts. (d) Overlap of NAD+ and triclosan pairs from known ENR structures: T. thermophilus (C atoms in cyan), E. coli (C atoms in brown), M. tuberculosis (C atoms in yellow), P. falciparium (C atoms in salmon) and H. pylori (C atoms in grey).
When we structurally compare the ternary complex Tth ENR–NAD+–triclosan (subunit A of the NAD+/triclosan complex) with the NAD+/triclosan complex structures of ENRs from P. falciparium (PDB entry 1uh5; Pidugu et al., 2004 ▶), E. coli (PDB entry 1c14; Qiu et al., 1999 ▶), M. tuberculosis (PDB entry 1p45; Kuo et al., 2003 ▶) and H. pylori (PDB entry 2pd3; Lee et al., 2007 ▶), the r.m.s.d.s are 0.52 Å (for 136 Cα-atom pairs of structurally aligned residues), 0.76 Å (for 231 Cα-atom pairs), 0.97 Å (for 185 Cα-atom pairs) and 0.60 Å (for 221 Cα-atom pairs), respectively. Triclosan binds to each of them in the same way (Fig. 4 ▶ d).
3.3. Reasons for thermostability
Kumar et al. (2000 ▶) performed a statistical comparison of homologous high-resolution structures from thermophilic and mesophilic organisms. They found that thermostability is related to an increased number of salt bridges, an increased number of side-chain hydrogen bonds, a higher proportion of arginine and tyrosine residues and a lower proportion of cysteine and serine residues in the sequence, a higher proportion of residues in α-helical conformation and fewer prolines in α-helices. When compared with the E. coli and M. tuberculosis ENRs, there are indeed more arginines (18 versus 12 and 13) and tyrosines (nine versus seven and six) and fewer cysteines (zero versus three and one) and serines (ten versus 15 and 16) in the sequence. However, Tth ENR does not contain more α-helical residues than the E. coli and M. tuberculosis ENRs; also, there are not fewer prolines in these α-helices. As mentioned above, the presence of an extra N-terminal small β-strand (B0) in the structure, which forms a small two-stranded β-sheet with an equivalent partner from a neighbouring protein chain in the tetramer, is likely to stabilize the tetramer and may also contribute to thermostability. The Tth ENR structure contains many more salt bridges than the E. coli and M. tuberculosis structures (22 versus 13 and six salt bridges, respectively) and an almost equal number of side-chain hydrogen bonds interactions (20 versus 18 and 21 side-chain hydrogen bonds, respectively) (see Table 2 ▶). The thermostability of the Tth ENR may thus arise owing to the higher number of salt bridges that are present in its structure. In Tth ENR ten salt bridges are involved in tetramer formation and 12 salt bridges are involved in folding of the monomer, while in E. coli ENR eight salt bridges are involved in tetramer formation and five salt bridges stabilize the structure of the monomer.
4. Conclusion
The high-resolution structure of T. thermophilus enoyl-acyl carrier protein reductase has been described. The lid that covers the active site has been completely described in the apo protein for the first time, but no significant differences were found between the apo and the cofactor-coordinated dispositions of this loop. The structure of Tth ENR is quite similar to those of mesophilic strain ENRs. The main differences are related to the thermostability of the former: a higher number of arginine and tyrosine residues, a lower number of cysteine and serine residues, the presence of an extra intramolecular two-stranded β-sheet interaction and a higher number of salt bridges. Additionally, the high-resolution structures of NAD+ and NAD+/triclosan complexes with Tth ENR have been described. The binding mode of NAD+ and triclosan to the Tth ENR active site is similar to that in previously described ENRs. No binary complex between ENR and triclosan could be determined, which is consistent with an uncompetitive inhibition mode of triclosan with this protein. The binding of triclosan to the Tth ENR–NAD+ complex appears to prevent the release of NAD+.
Supplementary Material
PDB reference: Tth ENR, apo, 2wyu
PDB reference: complex with NAD+, 2wyv
PDB reference: complex with NAD+ and triclosan, 2wyw
Acknowledgments
T. thermophilus HB8 genomic DNA was kindly provided by Professor Wolfgang Liebl (Institute of Microbiology and Genetics, University of Göttingen, Germany). We thank Patricia Ferraces-Casais for excellent technical assistance and the ESRF and EMBL Hamburg beamline staff, Sergio G. Bartual and Bruno Dacunha-Marinho for help with data collection. This research was funded by contract STRP-15471 of the European Community Adventure programme (Artizymes Project) and by projects BFU2008-01588 and BFU2011-24843 from the Spanish Ministry of Science. JMO was funded by an Angeles Alvariño contract from the Xunta de Galicia.
References
- Baldock, C., Rafferty, J. B., Sedelnikova, S. E., Baker, P. J., Stuitje, A. R., Slabas, A. R., Hawkes, T. R. & Rice, D. W. (1996). Science, 274, 2107–2110. [DOI] [PubMed]
- Bergler, H., Wallner, P., Ebeling, A., Leitinger, B., Fuchsbichler, S., Aschauer, H., Kollenz, G., Högenauer, G. & Turnowsky, F. (1994). J. Biol. Chem. 269, 5493–5496. [PubMed]
- Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. [DOI] [PMC free article] [PubMed]
- Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R. & Sacchettini, J. C. (1995). Science, 267, 1638–1641. [DOI] [PubMed]
- Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. [DOI] [PubMed]
- Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
- Kim, K.-H., Ha, B. H., Kim, S. J., Hong, S. K., Hwang, K. Y. & Kim, E. E. (2011). J. Mol. Biol. 406, 403–415. [DOI] [PubMed]
- Kim, S. J., Ha, B. H., Kim, K.-H., Hong, S. K., Shin, K.-J., Suh, S. W. & Kim, E. E. (2010). Biochem. Biophys. Res. Commun. 400, 517–522. [DOI] [PubMed]
- Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. [DOI] [PubMed]
- Kumar, S., Tsai, C.-J. & Nussinov, R. (2000). Protein Eng. 13, 179–191. [DOI] [PubMed]
- Kuo, M. R. et al. (2003). J. Biol. Chem. 278, 20851–20859. [DOI] [PubMed]
- Laemmli, U. K. (1970). Nature (London), 227, 680–685. [DOI] [PubMed]
- Lee, H. H., Moon, J. & Suh, S. W. (2007). Proteins, 69, 691–694. [DOI] [PubMed]
- Leibundgut, M., Maier, T., Jenni, S. & Ban, N. (2008). Curr. Opin. Struct. Biol. 18, 714–725. [DOI] [PubMed]
- Leslie, A. G. W. (2006). Acta Cryst. D62, 48–57. [DOI] [PubMed]
- Levy, C. W., Roujeinikova, A., Sedelnikova, S., Baker, P. J., Stuitje, A. R., Slabas, A. R., Rice, D. W. & Rafferty, J. B. (1999). Nature (London), 398, 383–384. [DOI] [PubMed]
- Lu, H., England, K., am Ende, C., Truglio, J. J., Luckner, S., Reddy, B. G., Marlenee, N. L., Knudson, S. E., Knudson, D. L., Bowen, R. A., Kisker, C., Slayden, R. A. & Tonge, P. J. (2009). ACS Chem. Biol. 4, 221–231. [DOI] [PMC free article] [PubMed]
- Lu, J. Z., Muench, S. P., Allary, M., Campbell, S., Roberts, C. W., Mui, E., McLeod, R. L., Rice, D. W. & Prigge, S. T. (2007). Parasitology, 134, 1949–1962. [DOI] [PMC free article] [PubMed]
- Massengo-Tiassé, R. P. & Cronan, J. E. (2009). Cell. Mol. Life Sci. 66, 1507–1517. [DOI] [PMC free article] [PubMed]
- McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. [DOI] [PMC free article] [PubMed]
- Muench, S. P., Prigge, S. T., McLeod, R., Rafferty, J. B., Kirisits, M. J., Roberts, C. W., Mui, E. J. & Rice, D. W. (2007). Acta Cryst. D63, 328–338. [DOI] [PMC free article] [PubMed]
- Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
- Nayal, M. & Di Cera, E. (1996). J. Mol. Biol. 256, 228–234. [DOI] [PubMed]
- Oshima, T. (1974). Seikagaku, 46, 887–907. [PubMed]
- Perozzo, R., Kuo, M., Sidhu, A. S., Valiyaveettil, J. T., Bittman, R., Jacobs, W. R., Fidock, D. A. & Sacchettini, J. C. (2002). J. Biol. Chem. 277, 13106–13114. [DOI] [PubMed]
- Pidugu, L. S., Kapoor, M., Surolia, N., Surolia, A. & Suguna, K. (2004). J. Mol. Biol. 343, 147–155. [DOI] [PubMed]
- Powell, H. R. (1999). Acta Cryst. D55, 1690–1695. [DOI] [PubMed]
- Priyadarshi, A., Kim, E. E. & Hwang, K. Y. (2010). Proteins, 78, 480–486. [DOI] [PubMed]
- Qiu, X., Janson, C. A., Court, R. I., Smyth, M. G., Payne, D. J. & Abdel-Meguid, S. S. (1999). Protein Sci. 8, 2529–2532. [DOI] [PMC free article] [PubMed]
- Rafi, S., Novichenok, P., Kolappan, S., Zhang, X., Stratton, C. F., Rawat, R., Kisker, C., Simmerling, C. & Tonge, P. J. (2006). J. Biol. Chem. 281, 39285–39293. [DOI] [PMC free article] [PubMed]
- Rossmann, M. G., Liljas, A., Granden, G. & Baraszak, L. (1975). The Enzymes, 3rd ed., edited by P. D. Boyer, Vol. XI, pp. 61–102. New York: Academic Press.
- Roujeinikova, A., Levy, C. W., Rowsell, S., Sedelnikova, S., Baker, P. J., Minshull, C. A., Mistry, A., Colls, J. G., Camble, R., Stuitje, A. R., Slabas, A. R., Rafferty, J. B., Pauptit, R. A., Viner, R. & Rice, D. W. (1999). J. Mol. Biol. 294, 527–535. [DOI] [PubMed]
- Roujeinikova, A., Sedelnikova, S., de Boer, G. J., Stuitje, A. R., Slabas, A. R., Rafferty, J. B. & Rice, D. W. (1999). J. Biol. Chem. 274, 30811–30817. [DOI] [PubMed]
- Schüttelkopf, A. W. & van Aalten, D. M. F. (2004). Acta Cryst. D60, 1355–1363. [DOI] [PubMed]
- Tipparaju, S. K., Mulhearn, D. C., Klein, G. M., Chen, Y., Tapadar, S., Bishop, M. H., Yang, S., Chen, J., Ghassemi, M., Santarsiero, B. D., Cook, J. L., Johlfs, M., Mesecar, A. D., Johnson, M. E. & Kozikowski, A. P. (2008). Chem. Med. Chem. 3, 1250–1268. [DOI] [PMC free article] [PubMed]
- Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
- Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R. & Sacchettini, J. C. (2007). J. Exp. Med. 204, 73–78. [DOI] [PMC free article] [PubMed]
- Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
PDB reference: Tth ENR, apo, 2wyu
PDB reference: complex with NAD+, 2wyv
PDB reference: complex with NAD+ and triclosan, 2wyw